| IRF4 transcription-factor-dependent CD103+ CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation EK Persson, H Uronen-Hansson, M Semmrich, A Rivollier, K Hägerbrand, ... Immunity 38 (5), 958-969, 2013 | 632 | 2013 |
| Mucosal T lymphocyte numbers are selectively reduced in integrin αE (CD103)-deficient mice MP Schön, A Arya, EA Murphy, CM Adams, UG Strauch, WW Agace, ... The Journal of Immunology 162 (11), 6641-6649, 1999 | 565 | 1999 |
| CCL25 mediates the localization of recently activated CD8αβ+ lymphocytes to the small-intestinal mucosa M Svensson, J Marsal, A Ericsson, L Carramolino, T Brodén, G Márquez, ... The Journal of clinical investigation 110 (8), 1113-1121, 2002 | 414 | 2002 |
| Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation WW Agace, A Amara, AI Roberts, JL Pablos, S Thelen, M Uguccioni, XY Li, ... Current Biology 10 (6), 325-328, 2000 | 255 | 2000 |
| Gut-associated lymphoid tissue–primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine H Stenstad, A Ericsson, B Johansson-Lindbom, M Svensson, J Marsal, ... Blood 107 (9), 3447-3454, 2006 | 241 | 2006 |
| Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis V Bergqvist, E Hertervig, P Gedeon, M Kopljar, H Griph, S Kinhult, ... Cancer Immunology, Immunotherapy 66, 581-592, 2017 | 226 | 2017 |
| Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity T Mandl, J Marsal, P Olsson, B Ohlsson, K Andréasson Arthritis research & therapy 19, 1-7, 2017 | 133 | 2017 |
| Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG) C Eriksson, J Marsal, D Bergemalm, L Vigren, J Björk, M Eberhardson, ... Scandinavian journal of gastroenterology 52 (6-7), 722-729, 2017 | 125 | 2017 |
| Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease K Andréasson, Z Alrawi, A Persson, G Jönsson, J Marsal Arthritis research & therapy 18, 1-8, 2016 | 113 | 2016 |
| CD8αβ+ γδ T cells: a novel T cell subset with a potential role in inflammatory bowel disease M Kadivar, J Petersson, L Svensson, J Marsal The Journal of Immunology 197 (12), 4584-4592, 2016 | 86 | 2016 |
| Effects of vedolizumab therapy on extraintestinal manifestations in inflammatory bowel disease M Fleisher, J Marsal, SD Lee, LE Frado, A Parian, BI Korelitz, BG Feagan Digestive diseases and sciences 63, 825-833, 2018 | 72 | 2018 |
| Targeting T‐cell migration in inflammatory bowel disease J Marsal, WW Agace Journal of internal medicine 272 (5), 411-429, 2012 | 72 | 2012 |
| Involvement of CCL25 (TECK) in the generation of the murine small‐intestinal CD8α α+CD3+ intraepithelial lymphocyte compartment J Marsal, M Svensson, A Ericsson, AH Iranpour, L Carramolino, ... European journal of immunology 32 (12), 3488-3497, 2002 | 61 | 2002 |
| Involvement of CCR9 at multiple stages of adult T lymphopoiesis M Svensson, J Marsal, H Uronen-Hansson, M Cheng, W Jenkinson, ... Journal of Leucocyte Biology 83 (1), 156-164, 2008 | 45 | 2008 |
| A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality P Holmkvist, K Roepstorff, H Uronen-Hansson, C Sandén, S Gudjonsson, ... Mucosal immunology 8 (3), 545-558, 2015 | 43 | 2015 |
| Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease V Bergqvist, M Kadivar, D Molin, L Angelison, P Hammarlund, M Olin, ... Therapeutic Advances in Gastroenterology 11, 1756284818801244, 2018 | 37 | 2018 |
| Real‐world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease V Bergqvist, J Holmgren, D Klintman, J Marsal Alimentary pharmacology & therapeutics 55 (11), 1389-1401, 2022 | 36 | 2022 |
| Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab K Andréasson, G Jönsson, P Lindell, A Gülfe, R Ingvarsson, E Lindqvist, ... Rheumatology 54 (2), 369-371, 2015 | 36 | 2015 |
| Large expert-curated database for benchmarking document similarity detection in biomedical literature search P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ... Database 2019, 2019 | 34 | 2019 |
| Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients L Angelison, S Almer, A Eriksson, P Karling, U Fagerberg, J Halfvarson, ... Alimentary pharmacology & therapeutics 45 (4), 519-532, 2017 | 33 | 2017 |
